SB 222200
SIGMA/S5192 - ≥98% (HPLC), solid
Synonym: (S)
CAS Number: 174635-69-9
Empirical Formula (Hill Notation): C26H24N2O
Molecular Weight: 380.48
MDL Number: MFCD00944072
Linear Formula: C26H24N2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | light yellow |
| form | solid |
| InChI | 1S/C26H24N2O/c1-3-22(19-1 |
| InChI key | MQNYRKWJSMQECI-QFIPXVFZSA |
| originator | GlaxoSmithKline |
| Quality Level | 100 ![]() |
| SMILES string | CC[C@H](NC(=O)c1c(C)c(nc2 |
| solubility | DMSO: soluble ~28 mg/mL |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Application: | The pharmacodynamics profile of SB 222200 enables its use as a tool to study physiological and pathophysiological roles of NK-3 receptor in CNS-modulated behaviors. |
| Biochem/physiol Actions: | Non-peptide NK3 tachykinin receptor antagonist. |
| Biochem/physiol Actions: | SB 222200 is a 2-phenyl-4-quinolinecarbo |
| Features and Benefits: | This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Legal Information: | Sold for research purposes under agreement from GlaxoSmithKline |
| Packaging: | 10, 50 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

